Koninklijke DSM NV Company Profile (OTC:RDSMY)

About Koninklijke DSM NV (OTC:RDSMY)

Koninklijke DSM NV logoKoninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties. Its Performance Materials segment consists of DSM Engineering Plastics, DSM Dyneema, and DSM Resins and Functional Materials. Its Innovation Center segment serves as an enabler and accelerator of innovation within DSM, as well as providing support to the clusters. Its Corporate Activities segment includes various holding companies and corporate overheads. The Corporate Activities segment includes Sitech Services. The Company delivers its solutions in global markets, such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTC:RDSMY
  • CUSIP: N/A
  • Web: www.dsm.com
  • Market Cap: $14.68131 billion
  • Outstanding Shares: 699,599,000
Average Prices:
  • 50 Day Moving Avg: $19.17
  • 200 Day Moving Avg: $18.23
  • 52 Week Range: $14.50 - $20.30
  • Trailing P/E Ratio: 16.70
  • Foreward P/E Ratio: 16.45
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $10.01 billion
  • Price / Sales: 1.41
  • Book Value: $9.95 per share
  • Price / Book: 2.03
  • Annual Dividend: $0.41
  • Dividend Yield: 2.0%
  • EBIDTA: $1.42 billion
  • Net Margins: 7.85%
  • Return on Equity: 8.78%
  • Return on Assets: 4.19%
  • Debt-to-Equity Ratio: 0.44%
  • Current Ratio: 1.74%
  • Quick Ratio: 1.11%
  • Average Volume: 36,702 shs.
  • Beta: 1.15

Frequently Asked Questions for Koninklijke DSM NV (OTC:RDSMY)

What is Koninklijke DSM NV's stock symbol?

Koninklijke DSM NV trades on the OTC under the ticker symbol "RDSMY."

Who are some of Koninklijke DSM NV's key competitors?

Who are Koninklijke DSM NV's key executives?

Koninklijke DSM NV's management team includes the folowing people:

  • Robert J. Routs, Independent Chairman of the Supervisory Board
  • Feike Sijbesma, Chief Executive Officer and Chairman of the Managing Board
  • Tom de Swaan, Independent Deputy Chairman of the Supervisory Board
  • Geraldine Matchett, Chief Financial Officer, Member of the Managing Board
  • Dimitri de Vreeze, Member of the Managing Board
  • Victoria F. Haynes Ph.D., Independent Member of the Supervisory Board
  • Eileen Kennedy, Independent Member of the Supervisory Board
  • Pradeep Pant, Independent Member of the Supervisory Board
  • John Ramsay, Independent Member of the Supervisory Board
  • Pauline van der Meer Mohr, Independent Member of the Supervisory Board

How do I buy Koninklijke DSM NV stock?

Shares of Koninklijke DSM NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Koninklijke DSM NV's stock price today?

One share of Koninklijke DSM NV stock can currently be purchased for approximately $20.23.

MarketBeat Community Rating for Koninklijke DSM NV (OTC RDSMY)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  23 (Vote Underperform)
Total Votes:  47
MarketBeat's community ratings are surveys of what our community members think about Koninklijke DSM NV and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Koninklijke DSM NV (OTC:RDSMY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: N/A

Analysts' Ratings History for Koninklijke DSM NV (OTC:RDSMY)
DateFirmActionRatingPrice TargetDetails
9/1/2017HSBC Holdings plcInitiated CoverageBuyView Rating Details
3/28/2017Liberum CapitalUpgradeHold -> BuyView Rating Details
3/9/2017J P Morgan Chase & CoUpgradeUnderweight -> NeutralView Rating Details
(Data available from 9/25/2015 forward)


Earnings History for Koninklijke DSM NV (OTC:RDSMY)
No earnings announcements for this company have been tracked by MarketBeat.com


Earnings Estimates for Koninklijke DSM NV (OTC:RDSMY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20171$0.29$0.29$0.29
Q4 20171$0.28$0.28$0.28
(Data provided by Zacks Investment Research)


Dividend History for Koninklijke DSM NV (OTC:RDSMY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Koninklijke DSM NV (OTC:RDSMY)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for Koninklijke DSM NV (OTC:RDSMY)
Latest Headlines for Koninklijke DSM NV (OTC:RDSMY)
americanbankingnews.com logoKoninklijke DSM NV (RDSMY) Now Covered by HSBC Holdings plc
www.americanbankingnews.com - September 1 at 4:46 PM
americanbankingnews.com logoKoninklijke DSM NV (RDSMY) Forecasted to Earn FY2021 Earnings of $1.49 Per Share
www.americanbankingnews.com - August 3 at 5:00 PM
americanbankingnews.com logoJefferies Group Comments on Koninklijke DSM NV's Q3 2017 Earnings (OTC:RDSMY)
www.americanbankingnews.com - August 2 at 7:32 AM
americanbankingnews.com logoResearch Analysts Issue Forecasts for Koninklijke DSM NV's FY2017 Earnings (RDSMY)
www.americanbankingnews.com - July 21 at 10:10 AM
americanbankingnews.com logoFY2017 EPS Estimates for Koninklijke DSM Boosted by Analyst (RDSMY)
www.americanbankingnews.com - May 3 at 1:08 PM
americanbankingnews.com logoLiberum Capital Upgrades Koninklijke DSM (RDSMY) to Buy
www.americanbankingnews.com - March 28 at 11:06 PM


This page was last updated on 9/25/2017 by MarketBeat.com Staff